Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Glioblastoma 12Prostatic Neoplasms 11Lung Neoplasms 11Oropharyngeal Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Breast Neoplasms 9Glioma 8Urinary Bladder Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Neoplasm Metastasis 6Esophageal Neoplasms 6Mouth Neoplasms 5Carcinoma 5Burkitt Lymphoma 5Astrocytoma 5Sarcoma 4Pancreatic Neoplasms 4Laryngeal Neoplasms 4Gliosarcoma 4Carcinoma, Hepatocellular 4Brain Neoplasms 4Adenocarcinoma of Lung 4Adenocarcinoma Of Esophagus 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Stomach Neoplasms 3Rhabdomyosarcoma, Embryonal 3Rhabdomyosarcoma 3Rectal Neoplasms 3Neoplasms 3

Interventions

Rituximab 28acalabrutinib 15ibrutinib 14Cyclophosphamide 13venetoclax 10Lenalidomide 10CT-P10 10zanubrutinib 9Magnetic Resonance Spectroscopy 8obinutuzumab 7fludarabine 7Specimen Handling 7Cytarabine 7Bendamustine Hydrochloride 7pirtobrutinib 6Peripheral Blood Stem Cell Transplantation 6Biopsy 6glofitamab 5fludarabine phosphate 5Whole-Body Irradiation 5Cyclosporine 5brexucabtagene autoleucel 4Mycophenolic Acid 4Vincristine 3Stem Cell Transplantation 3Sirolimus 3Methotrexate 3Etoposide 3Doxorubicin 3Cyclosporins 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Mantle-Cell × Radiation × 90 days × Clear all
NCT04054167 2026-06-03

Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
51 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡